Peripheral blood DNA Methylation profiles are indicative of head and neck squamous cell carcinoma: An Epigenome-wide association study

Epigenetics

Volumn 7, Issue 3, 2012, Pages 291-299

  Langevin, Scott M ^a,b   Koestler, Devin C ^c   Christensen, Brock C ^c   Butler, Rondi A ^a   Wiencke, John K ^d   Nelson, Heather H ^e   Andres Houseman, E ^f   Marsit, Carmen J ^c   Kelsey, Karl T ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f OREGON STATE UNIVERSITY   (United States)

Author keywords

Biomarkers; Epigenetics; HNSCC; Infinium; Methylation arrayinclude dietary; Semi supervised RPMM

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; FIBROBLAST GROWTH FACTOR 4; GENOMIC DNA; HYAL2 PROTEIN; INTERLEUKIN 27; PLEKHA6 PROTEIN; SERPINF1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; WDR39 PROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LARYNX; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUTH CAVITY; PHARYNX; RECEIVER OPERATING CHARACTERISTIC; SERODIAGNOSIS; SMOKING; TUMOR LOCALIZATION; VIRUS INFECTION;

EID: 84858222362     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.7.3.19134     Document Type: Article

References (55)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010; 60:277-300; PMID:20610543; http://dx.doi.org/10.3322/caac.20073.
2. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114:806-16; PMID:15609302; http://dx.doi.org/10.1002/ijc.20740.
3. Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 2004; 31:726-33; PMID:15599850; http://dx.doi.org/10.1053/j.seminoncol.2004.09.013.
4. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6:963-8; PMID:13094644; http://dx.doi.org/10.1002/1097-0142(195309)6:5963::AID-CNCR28200605153.0.CO;2-Q.
5. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical and molecular entity. Semin Oncol 2004; 31:744-54; PMID:15599852; http://dx.doi.org/10.1053/j.seminoncol.2004.09.011.
6. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:622-35; PMID:11402272; http://dx.doi.org/10.1067/moe.2001.115392.
7. Day GL, Blot WJ, Austin DF, Bernstein L, Greenberg RS, Preston-Martin S, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco and other determinants. J Natl Cancer Inst 1993; 85:465-73; PMID:8445674; http://dx.doi.org/10.1093/jnci/85.6.465.
8. Levi F, Pasche C, La Vecchia C, Lucchini F, Franceschi S, Monnier P. Food groups and risk of oral and pharyngeal cancer. Int J Cancer 1998; 77:705-9; PMID:9688303; http://dx.doi.org/10.1002/(SICI)1097-0215(19980831)77:5705::AID-IJC83.0.CO;2-Z.
9. McLaughlin JK, Gridley G, Block G, Winn DM, Preston-Martin S, Schoenberg JB, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988; 80:1237-43; PMID:3418729; http://dx.doi.org/10.1093/jnci/80.15.1237.
10. Winn DM, Ziegler RG, Pickle LW, Gridley G, Blot WJ, Hoover RN. Diet in the etiology of oral and pharyngeal cancer among women from the Southern United States. Cancer Res 1984; 44:1216-22; PMID:6692405.
11. Zheng W, Blot WJ, Shu XO, Gao YT, Ji BT, Ziegler RG, et al. Diet and other risk factors for laryngeal cancer in Shanghai, China. Am J Epidemiol 1992; 136:178-91; PMID:1415140.
12. Pavia M, Pileggi C, Nobile CG, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr 2006; 83:1126-34; PMID:16685056.
13. Sturgis EM, Pytynia KB. After the smoke clears: environmental and occupational risks for carcinoma of the upper aerodigestive tract. Cancer J 2005; 11:96-103; PMID:15969982; http://dx.doi.org/10.1097/00130404-200503000-00002.
14. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 2001; 96:2013-8; PMID:11467626; http://dx.doi.org/10.1111/j.1572-0241.2001.03934.x.
15. Morrison MD. Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg 1988; 99:370-3; PMID:3148885.
16. Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988; 98:1195-9; PMID:3185074; http://dx.doi.org/10.1288/00005537-198811000-00009.
17. Toner M, O'Regan EM. Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 1. Head Neck Pathol 2009; 3:246-8; PMID:20596979; http://dx.doi.org/10.1007/s12105-009-0135-0.
18. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute 2010.
19. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008; 371:1695-709; PMID:18486742; http://dx.doi.org/10.1016/S0140-6736(08)60728-X.
20. Lee JM, Turini M, Botteman MF, Stephens JM, Pashos CL. Economic burden of head and neck cancer. A literature review. Eur J Health Econ 2004; 5:70-80; PMID:15452768; http://dx.doi.org/10.1007/s10198-003-0204-3.
21. Wineland AM, Stack BC Jr. Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature. Curr Opin Otolaryngol Head Neck Surg 2008; 16:113-6; PMID:18327029; http://dx.doi.org/10.1097/MOO.0b013e3282f5520a.
22. Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One 2008; 3:2656; PMID:18628976; http://dx.doi.org/10.1371/journal.pone.0002656.
23. Liggett TE, Melnikov A, Yi Q, Replogle C, Hu W, Rotmensch J, et al. Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecol Oncol 2011; 120:113-20; PMID:21056906; http://dx.doi.org/10.1016/j.ygyno.2010.09.019.
24. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 2009; 4:8274; PMID:20019873; http://dx.doi.org/10.1371/journal.pone.0008274.
25. Pedersen KS, Bamlet WR, Oberg AL, de Andrade M, Matsumoto ME, Tang H, et al. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls. PLoS One 2011; 6:18223; PMID:21455317; http://dx.doi.org/10.1371/journal.pone.0018223.
26. Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol 2011; 29:1133-9; PMID:21343564; http://dx.doi.org/10.1200/JCO.2010.31.3577.
27. Cassinotti E, Melson J, Liggett T, Melnikov A, Yi Q, Replogle C, et al. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. Int J Cancer 2011; PMID:22020530; http://dx.doi.org/10.1002/ijc.26484.
28. Wang L, Aakre JA, Jiang R, Marks RS, Wu Y, Chen J, et al. Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J Thorac Oncol 2010; 5:778-85; PMID:20421821; http://dx.doi.org/10.1097/JTO.0b013e3181d6e0b3.
29. Koestler DC, Marsit CJ, Christensen BC, Karagas MR, Bueno R, Sugarbaker DJ, et al. Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics 2010; 26:2578-2585; PMID:20834038; http://dx.doi.org/10.1093/bioinformatics/btq470.
30. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99:3740-3745; PMID:11891299; http://dx.doi.org/10.1073/pnas.052410099.
31. Houseman EA, Christensen BC, Yeh RF, Marsit CJ, Karagas MR, Wrensch M, et al. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 2008; 9:365; PMID:18782434; http://dx.doi.org/10.1186/1471-2105-9-365.
32. Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, et al. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis. Cancer Epidemiol Biomarkers Prev 2009; 18:2782-2489; PMID:19755648; http://dx.doi.org/10.1158/1055-9965.EPI-09-0493.
33. Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, et al. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 2009; 4:4941; PMID:19293934; http://dx.doi.org/10.1371/journal.pone.0004941.
34. Alhamarneh O, Amarnath SM, Stafford ND, Greenman J. Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? Head Neck 2008; 30:251-61; PMID:18172882; http://dx.doi.org/10.1002/hed.20739.
35. Horlock C, Shakib F, Jones NS, Sewell HF, Ghaemmaghami AM. Differential protein expression by dendritic cells from atopic and non-atopic individuals after stimulation by the major house dust mite allergen Der p 1. Int Arch Allergy Immunol 2009; 150:237-251; PMID:19494521; http://dx.doi.org/10.1159/000222676.
36. Monzon ME, Fregien N, Schmid N, Falcon NS, Campos M, Casalino-Matsuda SM, et al. Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation. J Biol Chem 2010; 285:26126-34; PMID:20554532; http://dx.doi.org/10.1074/jbc.M110.135194.
37. Yoshida H, Nakaya M, Miyazaki Y. Interleukin 27: a double-edged sword for offense and defense. J Leukoc Biol 2009; 86:1295-303; PMID:19801497; http://dx.doi.org/10.1189/jlb.0609445.
38. Issa JP, Garber JE. Time to think outside the (genetic) box. Cancer Prev Res (Phila) 2011; 4:6-8; PMID:21205738; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0348.
39. Hesson LB, Hitchins MP, Ward RL. Epimutations and cancer predisposition: importance and mechanisms. Curr Opin Genet Dev 2010; 20:290-8; PMID:20359882; http://dx.doi.org/10.1016/j.gde.2010.02.005.
40. Hitchins MP. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility. Adv Genet 2010; 70:201-43; PMID:20920750; http://dx.doi.org/10.1016/B978-0-12-380866-0.60008-3.
41. Kemler I, Schaffner W. Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression. FASEB J 1990; 4:1444-9; PMID:2407588.
42. Pankratova EV, Deyev IE, Zhenilo SV, Polanovsky OL. Tissue-specific isoforms of the ubiquitous transcription factor Oct-1. Mol Genet Genomics 2001; 266:239-45; PMID:11683265; http://dx.doi.org/10.1007/s004380100549.
43. Applebaum KM, McClean MD, Nelson HH, Marsit CJ, Christensen BC, Kelsey KT. Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer 2009; 124:2690-6; PMID:19230024; http://dx.doi.org/10.1002/ijc.24256.
44. Meschede W, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, et al. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol 1998; 36:475-80; PMID:9466762.
45. Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002; 106:61-70; PMID:12367730; http://dx.doi.org/10.1016/S0166-0934(02)00134-9.
46. Houseman E, Coull B, Ryan L. A functional-based distribution diagnostic for a linear model with correlated outcomes. Biometrika 2006; 93:911-26; http://dx.doi.org/10.1093/biomet/93.4.911.
47. Bair E, Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2004; 2:108; PMID:15094809; http://dx.doi.org/10.1371/journal.pbio.0020108.
48. Bair E, Hastie T. Prediction by supervised principal components. J Am Stat Assoc 2006; 101:119-37; http://dx.doi.org/10.1198/016214505000000628.
49. Poage GM, Houseman EA, Christensen BC, Butler RA, Avissar-Whiting M, McClean MD, et al. Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res 2011; 17:3579-89; PMID:21505061; http://dx.doi.org/10.1158/1078-0432.CCR-11-0044.
50. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009; 5:1000602; PMID:19680444; http://dx.doi.org/10.1371/journal.pgen.1000602.
51. Avissar-Whiting M, Koestler DC, Houseman EA, Christensen BC, Kelsey KT, Marsit CJ. Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma. Epigenetics 2011; 6:703-9; PMID:21610323; http://dx.doi.org/10.4161/epi.6.6.16158.
52. Christensen BC, Kelsey KT, Zheng S, Houseman EA, Marsit CJ, Wrensch MR, et al. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 2010; 6:1001043; PMID:20686660; http://dx.doi.org/10.1371/journal.pgen.1001043.
53. Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, et al. DNA methylation, isocitrate dehydrogenase mutation and survival in glioma. J Natl Cancer Inst 2011; 103:143-53; PMID:21163902; http://dx.doi.org/10.1093/jnci/djq497.
54. Rocke DM. On the beta transformation family. Technometrics 1993; 35:72-81; http://dx.doi.org/10.2307/1269291.
55. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-50; PMID:16199517; http://dx.doi.org/10.1073/pnas.0506580102.